QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Clinical trial NCT03136406 · TERMINATED
Trial details
- NCT number
- NCT03136406
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-11
- Primary completion
- 2017-11-22
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.